{"title":"Nrf2-mediated inhibition of ferroptosis contributes to the amelioration of atherosclerosis by polydatin","authors":"Yu Qiu Wu , Ruo Man Wu , Yi Zeng, Xiao Le Xu","doi":"10.1016/j.taap.2025.117538","DOIUrl":null,"url":null,"abstract":"<div><div>Polydatin is a bioactive compound extracted from the roots of Reynoutria japonica Houtt. It has demonstrated various protective effects on the cardiovascular system. However, the underlying molecular mechanisms through which polydatin exerts its effects in atherosclerosis (AS) remain largely unclear, particularly regarding the involvement of the ferroptosis pathway in its anti-atherosclerotic action. This study aims to investigate the anti-atherosclerotic effects of polydatin and its potential mechanisms, with a primary focus on the ferroptosis pathway. To this end, we employed an ApoE<sup>−/−</sup> mouse model and endothelial cells exposed to oxidized low-density lipoprotein (ox-LDL). We analyzed atherosclerosis progression, endothelial function, and ferroptosis both in vitro and in vivo using various biological and biochemical techniques. To further explore the underlying mechanisms of polydatin's effects, Nrf2 expression was silenced using siRNA. Polydatin inhibited atherosclerosis in vivo and improved endothelial function in vitro. We evaluated ferroptosis-related markers, including ferrous iron, glutathione, malondialdehyde, lipid reactive oxygen species (ROS), GPX4, and SLC7A11, as well as overall ROS production, mitochondrial membrane potential, and mitochondrial ROS. The results indicated that polydatin suppressed ferroptosis both in vivo and in vitro. Moreover, the ferroptosis inducer erastin counteracted the endothelial cytoprotective effects of polydatin. Mechanistically, polydatin significantly enhanced Nrf2 nuclear translocation in both the aortic tissues of ApoE<sup>−/−</sup> mice and ox-LDL-stimulated endothelial cells. Furthermore, silencing Nrf2 markedly abrogated the protective effects of polydatin on endothelial ferroptosis and impaired cellular function. Collectively, these findings demonstrate that modulating Nrf2-dependent ferroptosis contributes to the ability of polydatin to mitigate atherosclerosis and protect endothelial cells from injury.</div></div>","PeriodicalId":23174,"journal":{"name":"Toxicology and applied pharmacology","volume":"504 ","pages":"Article 117538"},"PeriodicalIF":3.4000,"publicationDate":"2025-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Toxicology and applied pharmacology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0041008X2500314X","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Polydatin is a bioactive compound extracted from the roots of Reynoutria japonica Houtt. It has demonstrated various protective effects on the cardiovascular system. However, the underlying molecular mechanisms through which polydatin exerts its effects in atherosclerosis (AS) remain largely unclear, particularly regarding the involvement of the ferroptosis pathway in its anti-atherosclerotic action. This study aims to investigate the anti-atherosclerotic effects of polydatin and its potential mechanisms, with a primary focus on the ferroptosis pathway. To this end, we employed an ApoE−/− mouse model and endothelial cells exposed to oxidized low-density lipoprotein (ox-LDL). We analyzed atherosclerosis progression, endothelial function, and ferroptosis both in vitro and in vivo using various biological and biochemical techniques. To further explore the underlying mechanisms of polydatin's effects, Nrf2 expression was silenced using siRNA. Polydatin inhibited atherosclerosis in vivo and improved endothelial function in vitro. We evaluated ferroptosis-related markers, including ferrous iron, glutathione, malondialdehyde, lipid reactive oxygen species (ROS), GPX4, and SLC7A11, as well as overall ROS production, mitochondrial membrane potential, and mitochondrial ROS. The results indicated that polydatin suppressed ferroptosis both in vivo and in vitro. Moreover, the ferroptosis inducer erastin counteracted the endothelial cytoprotective effects of polydatin. Mechanistically, polydatin significantly enhanced Nrf2 nuclear translocation in both the aortic tissues of ApoE−/− mice and ox-LDL-stimulated endothelial cells. Furthermore, silencing Nrf2 markedly abrogated the protective effects of polydatin on endothelial ferroptosis and impaired cellular function. Collectively, these findings demonstrate that modulating Nrf2-dependent ferroptosis contributes to the ability of polydatin to mitigate atherosclerosis and protect endothelial cells from injury.
期刊介绍:
Toxicology and Applied Pharmacology publishes original scientific research of relevance to animals or humans pertaining to the action of chemicals, drugs, or chemically-defined natural products.
Regular articles address mechanistic approaches to physiological, pharmacologic, biochemical, cellular, or molecular understanding of toxicologic/pathologic lesions and to methods used to describe these responses. Safety Science articles address outstanding state-of-the-art preclinical and human translational characterization of drug and chemical safety employing cutting-edge science. Highly significant Regulatory Safety Science articles will also be considered in this category. Papers concerned with alternatives to the use of experimental animals are encouraged.
Short articles report on high impact studies of broad interest to readers of TAAP that would benefit from rapid publication. These articles should contain no more than a combined total of four figures and tables. Authors should include in their cover letter the justification for consideration of their manuscript as a short article.